BiotechTube
Home/Capricor Therapeutics/Michael Binks, M.D.
MB

Michael Binks, M.D.

Chief Medical Officer

Capricor Therapeutics

Therapeutic Areas

Rare DiseasesNeuromuscularCardiologyInfectious Disease

Capricor Therapeutics Pipeline

DrugIndicationPhase
Deramiocel (CAP-1002)Duchenne Muscular Dystrophy (DMD)Phase 3
StealthX™ VaccineCOVID-19 (Booster)Phase 1
StealthX™ TherapeuticsOncology & Other TargetsPreclinical

Leadership Team at Capricor Therapeutics

LM
Linda Marbán, Ph.D.
Chief Executive Officer and Director
FL
Frank Litvack, M.D., FACC
Executive Chairman
KA
Kristi A. H. Elliott, Ph.D.
Chief Operating & Science Officer
View full Capricor Therapeutics profile